Muscle-invasive bladder cancer (MIBC) patients, eligible for neobladder reconstruction following radical cystectomy. research hub

A follow-up extension study of patients who completed the U-LaserPrint-1 clinical trial to evaluate the long-term safety and efficacy of treatment with InvivoLPrint-U.

This study is checking the long-term safety of a newly made replacement bladder in adults treated for bladder cancer. Researchers want to see how well the new bladder works over time, check for any long-lasting side effects, and find out if it improves everyday quality of life.